osimertinib,Durvalumab,Carboplatin,Paclitaxel,Cisplatin,Gemcitabine,Pemetrexed,Nivolumab,Ipilimumab,Vinorelbine,Docetaxel,Pembrolizumab
astrazeneca,merck,bms
['adaura', 'aura ,(-laura)']
#asco23 ca adaura os: adj osi vs. placebo x 3 yrs
1 5-yr os rate: 88% vs. 78%
2 well separated os curves at 5 yr
3 similar benefit among stages, chemo use
4 half in placebo arm had subqnt tx, of whom 88% had tki(43% had osi)
future : longer osi ?
more will be 
Hematology/Medical Oncology Fellow @RoswellPark
Thoracic Oncology Researcher
Future Asst Professor @UW & @FredHutch
Retweet ≠ endorsement
Views are my own